BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Metoclopramide

A dopamine D2 antagonist that is used as an antiemetic.

297+ PubMed studies analyzed · 86 RCTs · Evidence Score: 57.3

Research Domains

Metoclopramide has been studied across 20 research domains including 🧠 Focus & Attention, 🌤️ Mood & Depression, 💊 Pain, 🦠 Gut & Microbiome, 😴 Sleep. The primary research focus is 🧠 Focus & Attention with 22% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Metoclopramide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Quipazine
12 shared targets
Pergolide
18 shared targets
Cabergoline
14 shared targets
Piribedil
12 shared targets
Mianserin
20 shared targets
Mescaline
11 shared targets
Tamsulosin
12 shared targets
silodosin
11 shared targets
Amisulpride
9 shared targets
Yohimbine
15 shared targets
Loading evidence profile...

This evidence profile for Metoclopramide is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.